Carnes, A., Williams, J., Luke, J., Langtry, S., Hodgson, C., (2007) Rapid deployment plasmid production process combining inducible high yield fed-batch fermentation process with novel autolytic plasmid DNA purification. Mol. Ther. 15:S187-188. BioProcess Intl 3-9-Carnes.pdf

Carnes, A., Williams, J., (2007) Plasmid DNA manufacturing technology. Current Patents on Biotechnol. 1(2):151-166.C

Carnes, AE (2006) Fermentation Design for the manufacture of therapeutic plasmid DNA, Fermentation design for the manufacture of therapeutic plasmid DNA, BioProcess International, October, 2006"Mounted on the Internet with permission from BioProcess International”.

Carnes AE, Hodgson CP, Willims, JA. (2006) InducibleEscherichiacoli fermentation for increased plasmid DNA production. Biotechnol Appl Biochem. 45:155-166. "Mounted on the internet with permissiion from Portland Press.

James A Williams a,*, Jeremy Luke a, Lance Johnson a,b, Clague Hodgson, (2006)pDNAVACCultra vector family: high throughput intracellular targeting DNA vaccine plasmids. Nature Technology Corporation, 4701 Innovation Drive, Lincoln, NE 68521, USA. Vaccine 24:4671-4676;

Sciamanna I, Bargeri L, Martire A, Pittoggi C, Beralda R, Giordana R, Magnano AR, Hodgson C, Spadafora C. (2003) Sperm endogenous reverse transcriptase as mediator of new genetic information. biochem Biophys Res Commun 312: 1039-.

Hodgson, C.P., (2002) Gene Self-Assembly Technology (GENSA), in: G. Subramanian, Ed., Gene Therapy: Clinical, Scale-Up and Production, Elsevier Academic Publishers.

Grunkemeyer, J.A., Hodgson, C.P., Cosgrove, D. (2001) Sustained tissue-specific transgene expression from a VL30 retrotransposon-derived vector in vivo, Gene Ther. Mol. Biol. 6:91-99 (PDF).

Solaiman, F., Zink, M.A., Xu, G., Grunkemeyer, J., Cosgrove, D., Saenz., J., and Hodgson, C.P. (2000) Modular retro-vectors for transgenic and therapeutic use. Mol. Repro. & Dev. 56: 309-315

Sciamanna, I., Piccoli, S., Barberi, Zaccagnini, G., Magnano, A.R., Giordano, R., Campedelli, P., Hodgson, C.P., Lorenzini, R., and Spadafora, C. (2000) DNA-dose and sequence dependency in sperm-mediated gene transfer. Mol. Repro. & Dev. 56:301-305.

Xu, G., Hodgson, C.P. (2000) Fusogenic effects of murine retroviruses and cationic enhancers of transduction. Cancer Gene Therapy 7:53-58.

Hodgson, C.P. Xu. G., Solaiman, F., Zink, M.A. (1997) Progress toward synthetic retro-vectoring systems for gene therapy. J. Mol. Med. 75:249-258.

Hodgson, C.P., Zink, M.A., Xu, G.-P. (1999) Chimeric viral packaging signal without gag gene sequences. World Patent Publication WO 99/25862.

Chakraborty, A.K., Hodgson, C.P., (1998) Role of far upstream sequences regulating the rat Ha-ras gene expression. Biochem. Biophys. Res. Commun. 252:716-722.

Hodgson, C.P. Xu. G., Solaiman, F., Zink, M.A. (1997) Progress toward synthetic retro-vectoring systems for gene therapy. J. Mol. Med. 75:249-258.

Hodgson, C.P. and Solaiman, F. (1996). Virosomes: Cationic liposomes enhance retroviral transduction. Nature Biotechnol. 14:339-342.

Hodgson, C.P. (1996) Biosynthetic Virus Vectors for Gene Therapy. World Intellectual Property Organization (WIPO) Patent Publication WO 96/26745, 41p.

Hodgson, C.P. (1995). The vector void in gene therapy. Bio/Technology 11:222-225.